Expertise in
14
conditions

Daniel Seehofer

Charité Campus Virchow
Berlin, BE, DE 
Expertise in
14
conditions
Charité Campus Virchow
Berlin, BE, DE 

Overview

Daniel Seehofer practices practicing medicine in Berlin, Germany.

Mr. Seehofer is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Liver Failure, Cholangiocarcinoma (Bile Duct Cancer), Liver Transplant, and Hepatectomy.

He is actively involved in clinical research, co-authoring 304 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Charité Campus Virchow
Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Open, Randomized, Multicenter Phase II Trial With Cetuximab /5-FU/FA/Irinotecan or Cetuximab/5-FU/FA /Irinotecan/Oxaliplatin in K-ras/B-raf Wild Type Patients or With Irinotecan/Oxaliplatin/5-FU/FA With or Without Bevacizumab in K-ras Mutant Patients as Neoadjuvant Treatment in Patients With Non- Resectable Colorectal Liver Metastases.
Open, Randomized, Multicenter Phase II Trial With Cetuximab /5-FU/FA/Irinotecan or Cetuximab/5-FU/FA /Irinotecan/Oxaliplatin in K-ras/B-raf Wild Type Patients or With Irinotecan/Oxaliplatin/5-FU/FA With or Without Bevacizumab in K-ras Mutant Patients as Neoadjuvant Treatment in Patients With Non- Resectable Colorectal Liver Metastases.
Enrollment Status: Unknown
Publish Date: September 11, 2019
Intervention Type: Drug
Study Phase: Phase 2

304 Total Publications

Imaging biomarkers of liver hypertrophy after portal vein embolization in patients with liver tumors: cholestasis, arterial hyperperfusion, and splenic response.
Imaging biomarkers of liver hypertrophy after portal vein embolization in patients with liver tumors: cholestasis, arterial hyperperfusion, and splenic response.
Journal: Abdominal radiology (New York)
Published: March 16, 2026

Frequently Asked Questions about Daniel Seehofer

Is Daniel Seehofer a top-rated expert for Liver Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Daniel Seehofer is classified as an Distinguished expert for Liver Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daniel Seehofer participate in research or clinical trials?

Yes. Daniel Seehofer has published 304 articles and abstracts on conditions like Liver Transplant. You can view a list of Daniel Seehofer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Seehofer's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile